Home › NDC Lookup › RxCUI directory › RxCUI 153666

Irbesartan 150 MG Oral Tablet [Avapro] — RxCUI 153666

RxNorm drug concept · Semantic branded drug
RxCUI 153666 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI153666
Official nameIrbesartan 150 MG Oral Tablet [Avapro]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAvapro 150 MG Oral Tablet
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Irbesartan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Irbesartan is used for two main things. First, it lowers high blood pressure, which helps protect you from serious events like stroke and heart attack. Second, if you have type 2 d...
  • Food doesn't affect how well irbesartan works, so you can take it with or without a meal — whatever fits your routine best. The most important thing is to take it around the same t...
  • Does it matter if I take it with food or at a certain time of day?
  • Most people do fine on irbesartan. The most common things you might notice are mild diarrhea, heartburn, fatigue, or occasional dizziness — especially when you stand up quickly. Th...
📖 Read our full Irbesartan guide →

🕸️ Concept Web — How Irbesartan 150 MG Oral Tablet [Avapro] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Irbesartan 150 MG Oral Tablet [Avapro] RxCUI 153666

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Irbesartan 83818
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Avapro 153668
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Irbesartan Oral Tablet 370704
    • Irbesartan Oral Product 1161332
    • Irbesartan Pill 1161333
    • Irbesartan Oral Tablet [Avapro] 379722
    • Avapro Oral Product 1175669
    • Avapro Pill 1175670
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Irbesartan 150 MG Oral Tablet SCD · 200095
  • Irbesartan 150 MG SCDC · 316098
  • Irbesartan Oral Tablet SCDF · 370704
  • Irbesartan Oral Product SCDG · 1161332
  • Irbesartan Pill SCDG · 1161333

Brand-Name Concepts

  • Irbesartan 150 MG [Avapro] SBDC · 565355
  • Irbesartan Oral Tablet [Avapro] SBDF · 379722
  • Avapro Oral Product SBDG · 1175669
  • Avapro Pill SBDG · 1175670
  • Avapro BN · 153668

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 153666 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00024-5851-30 30 TABLET, FILM COATED in 1 BOTTLE (0024-5851-30) Avapro Sanofi-Aventis U.S. LLC 2013-01-01
00024-5852-30 30 TABLET, FILM COATED in 1 BOTTLE (0024-5852-30) Avapro Sanofi-Aventis U.S. LLC 2013-01-01
Observed labelers: Sanofi-Aventis U.S. LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.